AU1910299A - Peptidomimetic template-based combinatorial libraries - Google Patents

Peptidomimetic template-based combinatorial libraries

Info

Publication number
AU1910299A
AU1910299A AU19102/99A AU1910299A AU1910299A AU 1910299 A AU1910299 A AU 1910299A AU 19102/99 A AU19102/99 A AU 19102/99A AU 1910299 A AU1910299 A AU 1910299A AU 1910299 A AU1910299 A AU 1910299A
Authority
AU
Australia
Prior art keywords
peptidomimetic
template
combinatorial libraries
based combinatorial
libraries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19102/99A
Inventor
Cynthia Lynn Cwi
William Leonard Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1910299A publication Critical patent/AU1910299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
AU19102/99A 1997-12-18 1998-12-11 Peptidomimetic template-based combinatorial libraries Abandoned AU1910299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6802597P 1997-12-18 1997-12-18
US60068025 1997-12-18
PCT/US1998/026387 WO1999031507A1 (en) 1997-12-18 1998-12-11 Peptidomimetic template-based combinatorial libraries

Publications (1)

Publication Number Publication Date
AU1910299A true AU1910299A (en) 1999-07-05

Family

ID=22079953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19102/99A Abandoned AU1910299A (en) 1997-12-18 1998-12-11 Peptidomimetic template-based combinatorial libraries

Country Status (2)

Country Link
AU (1) AU1910299A (en)
WO (1) WO1999031507A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932213B2 (en) 1999-05-11 2011-04-26 President And Fellows Of Harvard College Small molecule printing
US6683191B2 (en) * 2000-06-05 2004-01-27 Ortho-Mcneil Pharmaceuticals, Inc. Method for synthesis of substituted azole libraries
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
TW200307667A (en) 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
PE20050249A1 (en) * 2003-07-25 2005-06-01 Aventis Pharma Gmbh NEW CYANOPYRROLIDES AND PROCEDURE FOR THEIR PREPARATION AS MEDICINES
US7094800B2 (en) 2003-07-25 2006-08-22 Sanofi-Aventis Deutschland Gmbh Cyanopyrrolidides, process for their preparation and their use as medicaments
US7008957B2 (en) 2003-07-25 2006-03-07 Sanofi-Aventis Deutschland Gmbh Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
DE10333935A1 (en) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh New bicyclic cyano-heterocycles, process for their preparation and their use as pharmaceuticals
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
JO2998B1 (en) 2010-06-04 2016-09-05 Amgen Inc Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
WO2013049250A1 (en) 2011-09-27 2013-04-04 Amgen Inc. Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AU2014223547B2 (en) 2013-02-28 2017-11-16 Amgen Inc. A benzoic acid derivative MDM2 inhibitor for the treatment of cancer
WO2014151863A1 (en) 2013-03-14 2014-09-25 Amgen Inc. Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer
JOP20200296A1 (en) 2013-06-10 2017-06-16 Amgen Inc Processes of Making and Crystalline Forms of a MDM2 Inhibitor

Also Published As

Publication number Publication date
WO1999031507A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU8755798A (en) Polyvalent and polyclonal libraries
AU3272295A (en) Soluble combinatorial libraries
AU1910299A (en) Peptidomimetic template-based combinatorial libraries
AU9383198A (en) Amine compounds and combinatorial libraries comprising same
AU9525298A (en) Anchored retaining wall system
GB9700504D0 (en) Pharmaceutical compounds
AU5387898A (en) Pharmaceutical agents
AUPO520597A0 (en) Space filling methods
AU5374098A (en) Combinatorial libraries of imidazol-pyrido-indoles and imidazol-pyrido-benzothiophene derivatives
AU6895598A (en) Combinatorial libraries of peptidomimetic macrocycles and processes therefor
AU7830298A (en) Combinatorial enzymatic complexes
AU5198698A (en) Combinatorial hydroxy-amino acid amide libraries
AU8591898A (en) Pharmaceutical compounds
AUPP737298A0 (en) Combinatorial libraries
EP0988559A4 (en) Self calibrating radar system
GB9716244D0 (en) Pharmaceutical compounds
AU6957098A (en) Polyvalent presenter combinatorial libraries and their uses
IL135039A0 (en) Combinatorial antisense library
AU2002219318A1 (en) System and methord for combinatorial library design
AU8849398A (en) Combinatorial library
AU1415299A (en) Tunnel sensor
AU8147798A (en) Peptido oligonucleotides (pons) and their combinatorial libraries
AU5130300A (en) Combinatorial metabolic libraries
AU1093197A (en) Combinatorial libraries
AU7624298A (en) Aminobenzenedicarboxylic acid-based combinatorial libraries